Using the yeast two-hybrid system, we isolated a cDNA encoding a novel human protein, named Pir51, that strongly interacts with human Rad51 recombinase. Analysis in vitro confirmed the interaction between Rad51 and Pir51. Pir51 mRNA is expressed in a number of human organs, most notably in testis, thymus, colon and small intestine. The Pir51 gene locus was mapped to chromosome 12p13.1-13.2 by fluorescence in situ hybridization. The Pir51 protein was expressed in Escherichia coli and purified to near homogeneity. Biochemical analysis shows that the Pir51 protein binds both single-and double-stranded DNA, and is capable of aggregating DNA. The protein also binds RNA. The Pir51 protein may represent a new member of the multiprotein complexes postulated to carry out homologous recombination and DNA repair in mammalian cells.
INTRODUCTION
Eukaryotic Rad51 protein is a homolog of bacterial RecA recombinase, which plays a central role in homologous recombination by carrying out the pairing of homologous DNA molecules and initiating the strand exchange reaction (1, 2) . Both genetic and biochemical data suggest that Rad51 protein is intimately involved in a variety of recombination events in the eukaryotic cell. In Saccharomyces cerevisiae, the RAD51 gene belongs to the RAD52 epistasis group of genes, mutations in which show defects in genetic recombination and repair of double-strand breaks in mitosis and meiosis (3) . Vertebrate Rad51 homologs are highly expressed in reproductive and lymphoid organs (4) (5) (6) . Nuclear foci of Rad51 protein are detected on synaptonemal complexes of mouse spermatocytes (7, 8) , in cultured human cells after DNA damage (7) , in stimulated lymphocytes (9) and in primary murine B cells that undergo class switch recombination (10) . The formation of a RecA-like nucleoprotein filament on single-and double-stranded DNA, DNA-dependent ATPase activity, homologous pairing and strand exchange reactions further support the premise that the Rad51 protein is a eukaryotic homolog of the RecA protein (11) (12) (13) (14) (15) .
Considering the biochemical complexity of recombination systems in eukaryotes, it is conceivable that the Rad51 protein would interact with other proteins. Most of the data on Rad51 interactions come from analysis in budding yeast. A number of genetic interactions among members of the RAD52 epistasis group have been established and some of these interactions were confirmed by use of the yeast two-hybrid system and biochemical analysis in vitro. In particular, yeast Rad51 protein was shown to interact with yeast Rad52, Rad54 and Rad55 proteins (16) (17) (18) (19) . Recently, the Rad51-Rad52 and Rad51-Rad54 interaction of mammalian proteins was also demonstrated (20, 21) .
The fact that the mammalian Rad51 gene is essential for cell proliferation (22) , whereas the RAD51 gene of baker's yeast is not, suggests the former's involvement in some very fundamental processes that might include replication and chromosome segregation, as well as DNA repair and recombination. Indeed, human Rad51 protein has been shown to interact in vitro and/or in vivo with the tumor suppressors p53 (23) , BRCA1 (24) and BRCA2 (25) and a ubiquitin-conjugating enzyme Ubc9 (26) . Clearly, further biochemical and genetic analysis of these and other Rad51 protein-protein interactions should greatly facilitate our understanding of the roles of Rad51 protein.
In this study, we present data on identification of a new protein that interacts with human Rad51 protein. The biochemical characterization of this novel protein, which we named Pir51, shows that it is capable of binding and aggregating DNA and binding RNA. The Pir51 protein might represent a novel member of a putative multiprotein recombination complex of mammalian cells.
MATERIALS AND METHODS

Two-hybrid system and DNA cloning
The two-hybrid system analysis of HsRad51 protein interactions was carried out as described previously (26) , using a Matchmaker two-hybrid cDNA library from HeLa S3 cells (Clontech). Two isolated clones that contained parts of Pir51 coding sequence were designated p13-3 and p23-10 ( Fig. 1) . To obtain the complete 5′ sequence of Pir51 cDNA, PCR was carried out from the *To whom correspondence should be addressed. Tel: +1 203 737 2942; Fax: +1 203 785 7023; Email: charles_radding@quickmail.yale.edu Matchmaker library, using primers EG280 (GAGATCCTAGAAC-TAGTGGATCC) and EG281 (CTTCACCAGGTG-CAAAGTCTGG). Primer EG280 is complementary to the vector sequence just upstream of the cDNA insert, and EG281 is complementary to a region of coding strand of Pir51 cDNA located between nt 533 and 551 from the 5′-end of clone p23-10. PCR amplification yielded an ∼700 bp fragment which was cloned in pCRII vector (Invitrogen) and then sequenced. An ATG codon was identified in this fragment that was located just 6 nt upstream of the 5′-end of the p23-10 clone.
Additional two-hybrid fusions of Pir51 protein with Gal4 DNA-binding and activation domains were made using vectors pGBT9 and pGAD GH, respectively, obtained from Clontech, as follows: to make plasmids pOK18 and pOK23 ( Fig. 1 and Table 1 ), a fragment of Pir51 coding sequence was amplified by PCR from clone p23-10 using primers EG256 (CGAGGATCC GATGGCTT-TAGATGACAAGCTC) and EG263 (CAGGAGATCTCCCAA-CCAAACATTCC). In both oligomers, homology with Pir51 nucleotide sequence is underlined. The PCR products were inserted into pGAD GH and pGBT9, respectively. To make plasmids pOK24 and pOK31, PCR was done from the Matchmaker library using primer EG287 (GTGGATCCACATATGGTGCGGCCTGTGA-GACATAAG) and EG263 (see above), and the resulting fragment inserted into pGAD GH and pGBT9, respectively. Two-hybrid interactions were quantitated in yeast reporter strain SFY526 (27) , using o-nitrophenyl-β-D-galactopyranoside as a substrate. The data presented in Table 1 are the average from experiments with at least three independent liquid cultures.
Isolation of a genomic clone of Pir51 and gene mapping
A human genomic DNA library in λ phage DASH II (Stratagene) was used for isolation of a genomic clone of Pir51. The phages (∼6 × 10 5 pfu) were plated on E.coli XL1-Blu MPA/2 (Stratagene) and plaques were transferred onto Hybond-N membrane (Amersham). The Pir51 cDNA insert from two-hybrid clone p23-10 was labeled with 32 P by random priming and used as a probe. Four positive genomic clones (numbered 5.1, 6.3, 8.1 and 8.2) were isolated, and PCR analysis confirmed that the clones contain Pir51 sequences. Clone 8.1 was labeled with digoxigenin-dUTP by nick translation and hybridized to normal human metaphase chromosomes together with an Alu repeat-specific oligonucleotide GM009 labeled with biotin (28) . Hybridization, post-hybridization washes and detection were done as previously described (29) . Digitized images were captured using a cooled CCD camera (Photometrics) attached to a Zeiss Axioskop fluorescence microscope. After pseudocoloring and merging, the position of the clone on chromosome 12 was determined initially from a few metaphase spreads that had both Alu banding and clone 8.1 signal. The band assignment was confirmed by FLpter (fractional length from pter) measurements (30) . A pool of clones 5.1, 6.3, 8.1 and 8.2 were also mapped in a separate experiment, with the same result.
Protein purification
The DNA fragment encoding the 23.3 kDa segment of the 36.7 kDa Pir51 protein ( Fig. 1) was amplified from the two-hybrid clone p23-10, using PCR with primers EG256 and EG263 (see above), that carry BamHI and BglII restriction sites, respectively. The Figure 1 . Maps of the plasmid constructs encoding a Rad51-interacting protein, Pir51, described in this study. Only Pir51-coding parts of the constructs are shown. The names of constructs used for protein expression are underlined; others are two-hybrid constructs. p13-3 and p23-10 are the two clones isolated in a two-hybrid screen. The sequence of an insert of 150 nucleotides present in p13-3, pOK24 and pOK32 (crosshatched) is shown underlined in Figure 2 . An internal ATG codon used for making some of the constructs is shown. fragment was inserted into pQE-31 expression vector (Qiagen), that had been digested with BamHI, producing plasmid pEG13. The plasmid was transformed into E.coli strain M15 carrying pREP4 plasmid (Qiagen). The bacteria were grown in LB medium containing 100 µg ampicillin/ml and 30 µg kanamycin/ml until OD 600 = 0.6. The protein was induced by the addition of 1 mM IPTG for 3 h. Cell lysis and protein purification in denaturing conditions on Ni-NTA resin (Qiagen) were carried out following instructions from the manufacturer. The 6× His-tagged Pir51 protein was eluted from a Ni-NTA column in 0.1 M Na-phosphate buffer, 8 M urea, 250 mM imidazole, pH 6.0. Refolding of the protein was achieved by step-wise dialysis at 4_C against buffer of 50 mM Na-phosphate, pH 6.2, 400 mM NaCl, 5 mM β-mercaptoethanol (β-ME) containing 4 M and then 2 M urea, for 2 h with each buffer, and then overnight against the same buffer without urea and containing 250 mM NaCl and 5% glycerol. The dialyzed protein was diluted three times with 50 mM Na-phosphate, pH 6.2, and loaded onto a Mono-S 5/5 column (Pharmacia), pre-equilibrated with 50 mM Na-phosphate, pH 6.2, 50 mM NaCl, 1 mM β-ME. The column was developed with a linear 0-1 M NaCl gradient. Pure Pir51 fractions from Mono-S were dialyzed against 20 mM Na-phosphate, pH 6.5, 150 mM NaCl, 2 mM β-ME, 0.1 mM EDTA and 5% glycerol, and stored at 4_C. Fig. 1 and text for details).
The DNA fragment encoding the 31.4 kDa form of Pir51 protein ( Fig. 1 ) was amplified by PCR from p23-10 using primers EG287 and EG263. After digestion with NdeI and BglII, it was ligated into expression vector pRSET B (Invitrogen), resulting in plasmid pOK28. The protein was expressed from this plasmid using IPTG induction in E.coli strain FB810 (obtained from Dr S.West, Imperial Cancer Research Fund, UK) that harbors plasmid pREP4, in a way similar to induction of the 23.3 kDa fragment of Pir51. The cells were lysed by a combination of lysozyme and freezing/thawing treatments in buffer of 50 mM Tris-HCl, pH 7.7, 75 mM NaCl, 1 mM EDTA, 2 mM β-ME, 1 mM PMSF. The lysate, cleared by centrifugation at 30 000 g for 30 min, was subjected to ammonium sulfate precipitation (40% saturation). The pellet was resuspended in and dialysed against the lysis buffer, and loaded on a column of DEAE-Sepharose CL-6B. Proteins eluted from DEAE-Sepharose by lysis buffer with 150 mM NaCl (without PMSF) were loaded on a Mono-Q column, which was developed with a linear 0-1 M NaCl gradient. Pir51 protein, which eluted at ∼250 mM NaCl, was dialysed against 50 mM Na-phosphate, pH 7.4, 0.5 mM EDTA, 2 mM β-ME and loaded on a Mono-S column. A linear 0-1 M NaCl gradient was applied, and Pir51 protein was eluted at ∼350 mM NaCl. The final fractions were dialyzed against storage buffer of 20 mM Na-phosphate, pH 7.4, 150 mM NaCl, 0.1 mM EDTA, 2 mM β-ME, 5% glycerol and stored at 4_C.
Human Rad51 protein was expressed in E.coli and purified as described earlier (15) .
Interaction of HsRad51 and Pir51 proteins in vitro
The protein binding reaction (20 µl) contained 20 mM Tris-HCl, pH 7.2, 25 mM NaCl, 2 mM MgCl 2 , 0.75 µM HsRad51 protein, 2.5 µM Pir51 protein (the 6× His-tagged 23.3 kDa fragment) and 50 µg BSA/ml. The control reaction contained no Pir51 protein. The proteins were incubated for 1 h at 22_C, after which a 2 µl aliquot was taken. Then, 5 µl of a 50% slurry of Ni-NTA beads equilibrated with reaction buffer plus 0.05% Tween-20 was added and incubation was continued for 15 min with occasional mixing. The reaction mixture was centrifuged at 800 g for 2 min, and 2.5 µl of supernatant was taken. The sedimented beads were washed five times with 200 µl of reaction buffer plus 0.05% Tween-20 and 50 mM imidazole, pH 8.0, and then proteins bound to the beads were eluted with 400 µl of the same buffer but with 300 mM imidazole. The presence of Rad51 protein in various fractions was analyzed by 'dot-Western': the aliquots taken before addition of the beads and after incubation with the beads were diluted 50, 150, 450 and 1350 times in reaction buffer and 3 µl of each dilution spotted on nitrocellulose membrane (Biotrace NT, Gelman Sciences); similarly, 3 µl of 3-, 9-, 27-and 81-fold diluted eluate from the beads was spotted. Rad51 protein was detected by using polyclonal rabbit anti-Rad51 antibody and alkaline phosphatase-conjugated antirabbit IgG.
Binding of Pir51 protein to DNA
Binding of Pir51 protein to DNA was studied by a gel-mobility shift assay as follows. Reactions were carried out at 22_C in a binding buffer of 20 mM Tris-HCl, pH 7.2, 50 mM NaCl, 1 mM MgCl 2 and 50 µg BSA/ml. Pir51 protein (either 23.3 or 31.4 kDa form) was pre-incubated for 5 min at various concentrations in reaction buffer, and then radiolabeled single-stranded oligonucleotide W16(-) (15) was added at a final concentration of 3 µM (in terms of nucleotides). Incubation was continued for 15 min at room temperature, after which the reaction mixture was analyzed on a 0.8% agarose gel run in 40 mM Tris-acetate, pH 7.4. The same conditions were used for the study of binding of Pir51 to 6.4 kb long linear and circular double-stranded M13 DNA. To make labeled linear M13 DNA, the circular DNA was cut with BamHI and radiolabeled with [γ-32 P]ATP using T4 polynucleotide kinase. To visualize circular M13 duplex DNA in the gel-shift assay, the agarose gels were dried and hybridized with radiolabeled W16(-) oligonucleotide, which is complementary to a region of M13 DNA, following the procedure by M.Mather (31) .
For the DNA aggregation assay (32), 3.6 µM radiolabeled linear duplex M13 DNA was pre-incubated in the binding buffer for 15 min at 22_C with 1.2 µM Pir51 protein (31.4 kDa form) in 20 µl total reaction volume. Two 3 µl aliquots were taken ('pre-spin' fraction), and the rest of the reaction was spun down at 10 000 g in a microcentrifuge. Another two 3 µl aliquotes were taken ('supernatant' fraction), and 12 µl of 30% TCA was added to the remaining 8 µl of the reaction. After 15 min incubation on ice and 15 min centrifugation at 4_C, the TCA-soluble fraction was obtained. Two 7.5 µl aliquots of the TCA-soluble fraction, as well as the aliquots taken earlier, were Cherenkov counted. Counts obtained from TCA-soluble fractions were subtracted from values of the pre-spin and supernatant fractions. In parallel to this experiment, identical binding reactions were set up and analyzed directly on an agarose gel.
Binding of Pir51 protein to RNA
32 P-labeled RNA, ∼400 nt long, was produced by in vitro transcription from the T3 phage promotor of PvuII-linearized plasmid pRK100 as previously described (33) . About 1/13 of the transcription product (1.5 µl) was used for one binding reaction. Binding reactions and analysis of their products were carried out as in the study of Pir51-DNA interaction.
Northern analysis
A human multiple tissue Northern blot II (Clontech) was used to analyze Pir51 mRNA expression. The sequence of Pir51 insert in clone p23-10 was amplified by PCR. The resulting fragment was labeled with [α-32 P]dCTP by random priming and used as the hybridization probe.
RESULTS
Identification of a novel protein that interacts with human Rad51 protein
We used human Rad51 protein as a bait in a two-hybrid screen of a cDNA library prepared from human HeLa cells. Two positive clones with ∼2 kb cDNA inserts, named p23-10 and p13-3, were recovered. The inserts contained sequences that would code for polypeptides of 282 and 299 aa, respectively, fused to the Gal4 part of the two-hybrid vector. The nucleotide sequences of the clones were identical for most of their length, with the exception of an in-frame insert of 150 nt present in p13-3 (Fig. 1) . The use of PCR amplification (see Materials and Methods for details) allowed us to obtain additional sequence 5′ to that present in these cDNA clones and which contained a putative ATG initiation codon. The sequence context of this ATG codon, namely GGGACCATGG, matches well to the Kozak consensus sequence, GCCACCATGG (34) . The composite sequence of this Rad51-interacting clone is presented in Figure 2 . The longest open reading frame in this sequence encoded a protein of 335 aa that exhibited no significant homology to any currently known protein, and no well-defined structural motifs were apparent. Overall, the protein is quite hydrophilic, with lysine, arginine, glutamic and aspartic acid residues accounting for one-third of the amino acid composition. The predicted isoelectric point of the 335 aa protein is 9.95. We call this novel protein Pir51, for protein interacting with Rad51.
The 150 nt insert present in one of the two-hybrid clones most likely results from alternative mRNA splicing. The nucleotide sequence at its 5′-end, TTG◊GTGACT (the insert sequence is underlined), resembles the 5′ splice site of mammalian introns with consensus A/CAG◊GUA/GAGU (the intron sequence is A putative intron present in clone p13-3 (see Fig. 1 ) is underlined. The region between two arrows is absent in clone pOK27, thus giving rise to a frameshift and an altered C-terminus of the protein.
underlined), in which the GU dinucleotide at the beginning of intron is invariant. In addition, the AG dinucleotide characteristic of the 3′ splice junctions is present at the 3′-end of the insert. We therefore suggest that this insert represents an intron which gets spliced only in a subset of mRNAs. Interestingly, PCR analysis of cDNA prepared from human HeLa cells shows that this insert-containing form appears predominant (data not shown).
The full-length coding sequence of Pir51 was subcloned into yeast two-hybrid vectors and tested for its interaction with human Rad51 protein. In addition, we also subcloned and tested a shorter 215 aa long fragment of Pir51, that started with an internal methionine residue and lacked the 50 aa insert (Table 1 and Fig. 1) . The Rad51-Pir51 interaction was observed when either protein was fused to Gal4 DNA-binding or activation domain, and it appeared stronger when Rad51 was fused to the activation domain of Gal4. The 215 aa long form of Pir51 (constructs pOK18 and pOK23) produced stronger interactions than did the longer forms (constructs pOK24, pOK31, and the original p13-3 and p23-10 clones). Thus, sequences at the N-terminus of Pir51 protein seem not to be required for the interaction with Rad51 protein. In all cases, the strength of this interaction also appears to be comparable to or stronger than the Rad51 homotypic interaction. The interaction is specific for human Rad51 protein, as no interaction is observed with yeast Rad51 protein, or with human Dmc1 protein, a meiotic RecA/Rad51 homolog. In contrast to the self-association of HsRad51, no such association of Pir51 protein was found (Table 1) .
In an attempt to detect and characterize additional alternatively spliced forms of Pir51 mRNA, we amplified by PCR the Pir51 sequence from first strand cDNA of human HeLa cells. In one of the clones, named pOK27, an apparent splicing event had occurred between a 5′ splice site at the sequence AAG◊GUAAAA, that lies 57 nt upsteam from the one used in p23-10, and a 3′ splice site that is identical to the one used in p23-10, with the exception that rejoining occurred with a single nucleotide shift at the 3′ site (see Figs 1 and 2) . That resulted in a translation frameshift at the position of the 3′ splice site, and production of a Pir51 protein with an altered C-terminus (Fig. 1) . This form of Pir51 protein did not interact with Rad51 in the two-hybrid system (Table 1 ). This observation, and the lack of requirement for the N-terminus described above, indicate that interaction with Rad51 occurs via amino acid residues within the C-terminal region of Pir51.
We analyzed the expression pattern of Pir51 mRNA in various human organs and tissues by Northern analysis. A prominent transcript of ∼2.4 kb was detected in testis and thymus, and less intense expression was also found in colon and small intestine. Little or no expression was observed in spleen, prostate, ovary and peripheral blood leukocytes (data not shown).
Using a genomic clone of the Pir51 gene in λ phage as a probe, we carried out fluorescence in situ hybridization on human metaphase chromosomes. The Pir51 gene was mapped to human chromosome 12 in bands p13.1-13.2 with FLpter values ranging between 0.08 and 0.12 (Fig. 3) .
Purification of Pir51 protein and its in vitro interaction with HsRad51
We expressed in E.coli and purified to near homogeneity two forms of Pir51 protein: (i) the 215 aa fragment (predicted M r = 23.3 kDa) that starts from an internal ATG codon and lacks the 50 aa insert described above, and (ii) the 285 aa form (predicted M r = 31.4 kDa) that starts from the 5′-most ATG codon, and also lacks the insert (Fig. 2) . The first form, designated 6× His-Pir51, which contained a tag of six histidine residues on its N-terminus, was purified under denaturing conditions on Ni-NTA resin followed by renaturation of the protein (see Materials and Methods for details). The use of denaturing conditions reduced the amount of degradation products in the 6× His-Pir51 preparation. The second form of Pir51 was purified under native conditions by ion-exchange chromatography as described in Materials and Methods. The purification results are shown in Figure 4 . It is interesting that neither of the two forms migrates to the predicted position on SDS-PAGE gels. Instead, the 23.3 kDa form (plus 1.5 kDa tag) migrates as a polypeptide of ∼33 kDa, and the 31.4 kDa form as a ∼39 kDa protein. We note that both proteins are positively charged (predicted isoelectric points are 7.28 and 9.55, respectively), which may explain the observed migration differences.
The 6× His-tagged 23.3 kDa form of Pir51 was used to study the interaction with Rad51 in vitro. This form (but without the 6× His tag) shows the strongest interaction with Rad51 in the two-hybrid system (see above). In the binding experiment in vitro , 6× His-Pir51 was incubated with purified HsRad51 protein, then Ni-NTA beads that bind the 6× His tag were added, and Rad51 that remained associated with the beads after several washes was detected by using the dot-Western method (see Materials and Methods). In the control reaction, Pir51 protein was omitted. As shown in Figure 5 , there was a substantial retention of HsRad51 protein by the beads when Pir51 protein was present. In contrast, almost no Rad51 is detected on the beads without Pir51. This experiment shows that purified HsRad51 and Pir51 proteins interact in vitro.
Pir51 protein binds to DNA
The fact that Pir51 interacts with human Rad51 protein, which is a DNA-binding recombination enzyme, prompted us to examine whether Pir51 itself can bind DNA. A gel mobility shift assay was used for this purpose. First, two types of DNA substrates were utilized: (i) a single-stranded 83mer oligonucleotide, and (ii) linearized 6.4 kb double-stranded DNA of M13 phage. Indeed, we found that both 23.3 and 31.4 kDa forms of Pir51 protein bound both types of DNA in our assay (Figs 6 and 7B) . The binding to an oligonucleotide substrate was observed in a near-equimolar range of protein:nucleotide concentrations, whereas a lower protein:DNA ratio was sufficient to observe a gel mobility shift with long DNA. Moreover, at higher ratios of Ni-NTA beads were added, and after additional incubation and extensive washing, proteins bound to the beads were released by imidazole. The respective amounts of Rad51 present in reaction mixtures before adding the beads ('Before Ni-NTA'), in the supernatant after sedimentation of the beads ('Ni-NTA supernatant'), and in the released fraction ('Ni-NTA bound') were analyzed by dot-Western on a nitrocellulose membrane. Sequential 3-fold dilutions were spotted, from top to bottom, in each line.
Pir51:DNA, a high-molecular weight protein-DNA complex was formed that barely moved into the 0.8% agarose gel used in the assay (Fig. 6) . The binding of Pir51 to DNA, as detected by gel-shift assay, appears to be resistant to NaCl concentrations of up to at least 600 mM, and does not require Mg 2+ ions (data not shown). The reaction products were analyzed on 0.8% agarose gels. To visualize unlabeled DNA in (A), the gel was hybridized with 32 P-labeled oligonucleotide W16(-), which shares homology with M13 sequence, followed by autoradiography. The reactions were identical to the ones analyzed by gel mobility shift assay in Figure 7B . DNA aggregation was analyzed by centrifugation at 10 000 g for 3 min. Aliquots were taken for scincillation counting before and after centrifugation, and the fraction of soluble DNA was calculated.
The question whether DNA ends are required for Pir51 binding was also addressed. For this purpose, binding of Pir51 to circular double-stranded M13 phage DNA was studied. As shown in Figure 7A , Pir51 binds quite well to this type of DNA, as well as to the nicked dsM13 DNA present in the preparation. Likewise, Pir51 also bound circular single-stranded M13 DNA and produced a gel-shift (data not shown). Thus, Pir51 does not need DNA ends for binding.
The formation of a high-molecular weight Pir51-DNA complex, as revealed by gel-shift analysis, prompted us to investigate this complex further. Several DNA-binding proteins are known that are capable of aggregating DNA. One example is RecA protein, which promotes DNA aggregation upon pairing of homologous sequences present on different DNA molecules. In this case, a simple assay for aggregation consists of brief centrifugation of the reaction mixture containing radiolabeled DNA, and analyzing the partitioning of DNA between pellet and supernatant (32) . We analyzed for possible aggregation of linear duplex M13 DNA by Pir51 using this assay. Indeed, increasing Pir51 concentration led to almost complete precipitation of the formed protein-DNA complex after 3 min centrifugation at 10 000 g ( Table 2 ). Identical binding reactions in which centrifugation was omitted revealed the formation of a protein-DNA complex whose mobility in a gel assay was highly retarded (Fig. 7B) . Thus, both assays indicate that the Pir51 protein can aggregate DNA.
Since oligonucleotide-Pir51 complexes also are retained in the gel wells, we looked at whether these complexes can be sedimented by simple centrifugation at 10 000 g. Indeed, when such a complex was formed between Pir51 and W16(-) oligonucleotide, it could also be partially precipitated by centrifugation, albeit with lower efficiency than a complex of Pir51 with long duplex DNA (data not shown).
Pir51 binds to RNA
Using a gel mobility shift assay we have found that Pir51 protein (31.4 kDa form) binds to RNA (Fig. 8) . The binding takes place under the same conditions as binding of Pir51 to DNA. At higher Pir51 concentration the Pir51-RNA complexes do not enter a 0.8% agarose gel and can be found only in the wells. Thus, Pir51 protein binds to both DNA and RNA, and at higher concentrations produces high molecular weight aggregates.
DISCUSSION
In this study, we identified a novel protein that interacts with human Rad51 recombinase, the Pir51 protein. Biochemical analysis shows was incubated with ∼400 nt long 32 P-labeled RNA. The reaction products were analyzed by electrophoresis in 0.8% agarose gel followed by autoradiography. The highly shifted complex localizes to the gel wells.
that Pir51 is a DNA-binding protein that is capable of binding both single-and double-stranded DNA in a non-sequence specific manner and forming large protein-DNA complexes. The Pir51 protein also binds to RNA.
The best-characterized interactions of Rad51 protein are with the members of the yeast RAD52 epistasis group. It is presumed that proteins of this group may function together as a multiprotein complex in yeast cells, carrying out reactions of homologous recombination (17) . The molecular interactions within the RAD52 group seem to be conserved in higher eukaryotes as well, since interactions of human Rad51 with human Rad52 and Rad54 proteins were also identified (20, 21) . Other interactions of mammalian Rad51 protein include those with the breast and ovarian cancer-associated proteins BRCA1 and BRCA2 (24, 25) . These data point to the possible existence of several types of Rad51-containing protein complexes that may be involved in various aspects of homologous recombination and DNA repair. It is unclear at the moment what type of complex(es) Pir51 protein is a part of. Further analysis should be done to see whether Pir51 can also interact with other members of the RAD52 epistasis group, in particular with human Rad52 and Rad54 proteins. Our current data show that Pir51 does not interact with a meiosis-specific Rad51 homolog, the Dmc1 protein, and yeast Rad51 (Table 1) , or with the human ubiquitin-conjugating enzyme Ubc9 (data not shown), which interacts with Rad51 in the two-hybrid system (27) .
The Pir51 protein might have a role in regulation of the biochemical activities of Rad51. The strand-exchange activities of human and yeast Rad51 protein can be modulated by a eukaryotic single-stranded DNA binding protein, RPA (13, 35) . The effect of RPA can be further attenuated by a heterodimer of yeast Rad55 and Rad57 proteins. In particular, Rad55-Rad57 complex can relieve the inhibitory effect of high RPA concentration on the yeast Rad51-mediated strand exchange (36) . We may expect that Pir51 protein would affect some Rad51 reactions on DNA, especially taking into consideration the ability of the protein to bind and aggregate DNA. Similar properties are observed in many biologically interesting proteins. Some examples include RecA protein (32) , yeast strand exchange protein 1 (37) and its stimulatory factor SF1 (38) , yeast RPA (39) , various yeast single-stranded DNA-binding proteins (40) and histone proteins (41) . Aggregation of DNA can stimulate homologous pairing between single-and double-stranded DNA that can be followed by strand exchange (42) .
When our manuscript was in preparation, we learned about the study of Mizuta et al. (43) , in which a mouse protein, called Rab22, was cloned by virtue of its interaction with human Rad51 protein in the two-hybrid system. Sequence comparison shows that Rab22 appears to be a mouse homolog of Pir51, with 63% identity and 67% similarity at the amino acid level shared by the two proteins. The Rab22 gene was mapped by Mizuta et al. on mouse chromosome 6 to a region that corresponds to locus 12p13 on the human chromosome, consistent with our localization of Pir51 gene. Like Pir51, Rab22 protein also interacted with Rad51 in vitro, and the C-terminal portion of Rab22 was sufficient for this interaction. The latter is consistent with our analysis of clone pOK27. Moreover, Rab22 and Rad51 proteins were shown by Mizuta et al. to co-localize in nuclear foci in hamster cells that were co-transfected with Rab22 and Rad51 expression constructs. Taken together, these data point to a functional importance of the interaction between Rad51 and Pir51-Rab22 proteins. Further work is required to ascertain the functional significance of the biochemical properties of Pir51 protein described here, and the role it plays by interacting with Rad51.
